Ensuring drug safety : where do we go from here? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the Food and Drug Administration's process of ensuring drug safety, March 3, 2005 |
Descrizione fisica | 1 online resource (iii, 99 p.) : ill |
Soggetto topico |
Drugs - Safety regulations - United States
Drugs - United States - Testing |
Soggetto non controllato |
United States
Drugs Political science Medical |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Ensuring drug safety |
Record Nr. | UNINA-9910693918303321 |
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Evaluating the effectiveness of the Food And Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001 |
Descrizione fisica | 1 online resource (iii, 166 p.) |
Soggetto topico |
Pharmaceutical policy - United States
Drugs - United States - Testing Pediatric pharmacology - United States |
Soggetto non controllato |
United States
Pharmaceutical policy Drugs Pediatric pharmacology Political science Medical |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Evaluating the effectiveness of the Food And Drug Administration Modernization Act |
Record Nr. | UNINA-9910689420003321 |
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Examining patient access to investigational drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. October 3, 2017 |
Pubbl/distr/stampa | Washington : , : U.S. Government Publishing Office, , 2018 |
Descrizione fisica | 1 online resource (iv, 235 pages) : photographs |
Soggetto topico |
Clinical trials - United States
Clinical trials - Moral and ethical aspects - United States Drugs - United States - Testing Drugs - Testing - Moral and ethical aspects - United States |
Soggetto genere / forma | Legislative hearings. |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Examining patient access to investigational drugs |
Record Nr. | UNINA-9910711779603321 |
Washington : , : U.S. Government Publishing Office, , 2018 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005 |
Descrizione fisica | 1 online resource (iii, 93 p.) : ill |
Soggetto topico |
Drugs - United States - Testing
Pharmaceutical policy - United States |
Soggetto non controllato |
United States
Drugs Pharmaceutical policy Political science Medical |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | FDA's drug approval process |
Record Nr. | UNINA-9910693940603321 |
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
FDA's monitoring of postmarketing study commitments |
Pubbl/distr/stampa | [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2006 |
Descrizione fisica | 1 online resource (iv, 38 pages) : illustrations |
Soggetto topico |
Drugs - United States - Testing
Clinical trials - Government policy - United States |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti |
Food and Drug Administration's monitoring of postmarketing study commitments
FDA's monitoring of postmarketing study commitments |
Record Nr. | UNINA-9910707486603321 |
[Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2006 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
FDA's role in the evaluation of Avandia's safety [[electronic resource] ] : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, June 6, 2007 |
Pubbl/distr/stampa | Washington : , : U.S. G.P.O., , 2009 |
Descrizione fisica | iii, 138 pages : digital, PDF file |
Soggetto topico |
Rosiglitazone - Side effects
Diabetes - Chemotherapy Drugs - United States - Testing |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | FDA's role in the evaluation of Avandia's safety |
Record Nr. | UNINA-9910693458503321 |
Washington : , : U.S. G.P.O., , 2009 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
The Food and Drug Administration's critical mission and challenges for the future : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, May 1, 2007 |
Descrizione fisica | 1 online resource (iii, 79 p.) |
Soggetto topico |
Drugs - United States - Testing
Food adulteration and inspection - United States |
Soggetto non controllato |
United States
Drugs Food adulteration and inspection Political science Medical Technology & engineering |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Food and Drug Administration's critical mission and challenges for the future |
Record Nr. | UNINA-9910694472003321 |
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
The Food and Drug Administration's generic drug review process |
Pubbl/distr/stampa | [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2008 |
Descrizione fisica | 1 online resource (iii, 36 pages) : illustrations |
Soggetto topico |
Generic drugs - Government policy - United States
Drugs - United States - Testing |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Food and Drug Administration's generic drug review process |
Record Nr. | UNINA-9910707485903321 |
[Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2008 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Food and Drug Administration: information on Mifeprex labeling changes and ongoing monitoring efforts : report to congressional requesters |
Pubbl/distr/stampa | [Washington, D.C.] : , : United States Government Accountability Office, , 2018 |
Descrizione fisica | 1 online resource (ii, 29 pages) |
Soggetto topico |
Mifepristone - United States - Testing
Drugs - Labeling - Standards - United States Drugs - United States - Testing |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Food and Drug Administration |
Record Nr. | UNINA-9910706904703321 |
[Washington, D.C.] : , : United States Government Accountability Office, , 2018 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
From test tube to patient [[electronic resource] ] : improving health through human drugs / / Marcia L. Trenter, editor |
Pubbl/distr/stampa | [Rockville, MD] : , : U.S. Food and Drug Administration, Center for Drug Evaluation and Research, , [1999] |
Soggetto topico |
Drugs - Research - United States
Drugs - United States - Testing |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | From test tube to patient |
Record Nr. | UNINA-9910691221703321 |
[Rockville, MD] : , : U.S. Food and Drug Administration, Center for Drug Evaluation and Research, , [1999] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|